Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
8/5/2025
EMBIOS Secures Pre-A Funding to Advance First-in-Class Autoimmune Ther...
8/5/2025
Metis Raises CNY 400M in Series D to Fuel AI-Driven Drug Development
8/5/2025
Sanofi Attributes Praluent's China Exit to Global Supply Strain and St...
8/5/2025
China Biopharma Licensing Deals Soar in July, Driven by $500M Hengrui-...
8/5/2025
TenNor Files for Hong Kong IPO to Fund Breakthrough Antibacterial Prog...
8/5/2025
Sciwind in Talks to License Weight-Loss Drug to U.S. Partner, Eyes Glo...
8/5/2025
Sanofi Withdraws Praluent from China Amid Strategic Shift
8/4/2025
I-Mab Announces Pricing of $65M Underwritten Offering of ADS
8/2/2025
Sumitomo Pharma Completes Divestiture of China Business to Marubeni Gr...
8/2/2025
Attec Secures Strategic Series A Funding to Advance Protein Degrader P...
8/1/2025
Mabgeek Clinches CNY 260M Pre‑IPO Boost and Advances MG‑K10 Commerc...
8/1/2025
TenNor Therapeutics IPO Application Accepted by HKEX
8/1/2025
Lepu Biopharma Licenses Two T‑Cell Engagers to Excalipoint
8/1/2025
Everest Makes Strategic Equity Investment in I-Mab to Advance Oncology...
8/1/2025
Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Cand...
8/1/2025
China's Biotech Sector Faces Geopolitical Headwinds as Asia-Pacific Em...
8/1/2025
Wuxi AppTec Raises Nearly US$1B in Hong Kong to Fuel Global Expansion
7/31/2025
DarwinCell Breaks Ground with CNY 200M Series C Financing from Tsing C...
7/31/2025
Ancocare Closes Series B Financing to Fuel Oncolytic Virus Pipeline E...
7/31/2025
Leto Lab Secures Series D Financing Led by Hankang Capital
7/31/2025
R&B Bio Secures New Funding Round Led by SBI Holdings
7/31/2025
GE HealthCare Q2 Results Highlight Mixed Signals in China Amid Tariff ...
7/30/2025
AstraZeneca's Lynparza Gains Approval for New Indication in China
7/30/2025
J&J's Lazcluze Approved for NSCLC in China
7/30/2025
Madrigal Secures Global Rights to CSPC's Oral GLP-1 Candidate in Majo...
7/30/2025
Dr. Falk Pharma and Allianthera Partner to Advance Novel AhR Agonist f...
7/30/2025
Zhongmou Thera Secures Major Funding to Advance Gene Therapy Pipleline
7/29/2025
Merck Faces China Headwinds as Gardasil Pause Drags on Q2 Results
7/29/2025
ImageneBio Debuts on Nasdaq After Inmagene and Ikena Merger with $75M ...
7/29/2025
LTZ Therapeutics Teams Up with Eli Lilly to Propel Autoimmune Drug Inn...
Page:
3
/
25
Total number of articles:
735
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit